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Dual Role of COUP-TF-Interacting Protein 2 in
Epidermal Homeostasis and Permeability Barrier
Formation
Olga Golonzhka1, Xiaobo Liang2, Nadia Messaddeq3,4, Jean-Marc Bornert3,4, Adam L. Campbell2,
Daniel Metzger3,4, Pierre Chambon3,4, Gitali Ganguli-Indra2, Mark Leid2,5 and Arup K. Indra2,5
COUP-TF-interacting protein 2 (CTIP2; also known as Bcl11b) is a transcription factor that plays key roles in the
development of the central nervous and immune systems. CTIP2 is also highly expressed in the developing
epidermis, and at lower levels in the dermis and in adult skin. Analyses of mice harboring a germline deletion of
CTIP2 revealed that the protein plays critical roles in skin during development, particularly in keratinocyte
proliferation and late differentiation events, as well as in the development of the epidermal permeability barrier.
At the core of all of these actions is a relatively large network of genes, described herein, that is regulated
directly or indirectly by CTIP2. The analysis of conditionally null mice, in which expression of CTIP2 was ablated
specifically in epidermal keratinocytes, suggests that CTIP2 functions in both cell and non-cell autonomous
contexts to exert regulatory influence over multiple phases of skin development, including barrier establish-
ment. Considered together, our results suggest that CTIP2 functions as a top-level regulator of skin
morphogenesis.
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INTRODUCTION
The development of the skin epidermis begins with the
commitment of the primitive ectoderm to the keratinocyte
cell fate. The subsequent processes of cellular proliferation,
stratification, and differentiation result in formation of the
multilayered structure of epidermis. During embryonic
development, keratinocytes of the innermost layer of the
epidermis, the proliferative, basal cell layer, undergo a
program of the terminal differentiation, then exit the basal
cell layer and migrate upward to the surface of the skin
(Byrne et al., 2003; Mack et al., 2005). These cells initially
differentiate into spinous and then granular cells, and finally
into the tough, enucleated cells of the cornified layer, the
corneocytes (Byrne et al., 2003).
The events of epidermal development are orchestrated by
the concerted action of a number of transcription factors that
regulate both the proliferative capacity and differentiative
potential of epidermal keratinocytes (Segre, 2003, 2006).
These include c-Myc, p63, Klf4, GATA3, the AP-1 transcrip-
tion factors c-Fos and c-Jun, the Id family of proteins, and
others (Segre et al., 1999; Langlands et al., 2000; Angel et al.,
2001; Arnold and Watt, 2001; Shaulian and Karin, 2002;
Koster et al., 2004, 2007; de Guzman Strong et al., 2006).
The end product of epidermal development is the formation
of the epidermal permeability barrier (EPB), which provides a
crucial physical and permeability barrier.
Formation of the EPB is a stepwise and orderly process
(Segre, 2003, 2006). In the granular layer of epidermis, lipids
are packaged inside lamellar bodies, and structural proteins,
such as keratins, loricrin and filaggrin, are assembled into
macrofibrils. The cornified envelope (CE) is formed by
deposition of precursor proteins on the inner surface of the
plasma membrane (Elias, 2005). Transglutaminase enzymes
then cross-link the CE proteins, creating a tough sac that
holds the keratin fibers (Candi et al., 2005). Finally, cellular
organelles, including the nucleus, are degraded and lipids
from lamellar bodies are extruded into the intercellular space
and onto the CE scaffold, forming a series of extracellular
lipid membranes (lamellar bilayers; Candi et al., 2005).
COUP-TF-interacting protein 2 (CTIP2) is a C2H2 zinc
finger transcription factor that represses transcription of
reporter genes in transiently transfected cells, either by
tethering to other promoter-bound transcription factors
(Avram et al., 2000) or by direct, sequence-specific
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DNA-binding activity (Avram et al., 2002; Topark-Ngarm
et al., 2006). The hypothesis that CTIP2 functions as a
transcriptional regulator has been supported by transcriptome
analyses in human neuroblastoma cells (Topark-Ngarm et al.,
2006), striatal medium spiny neurons (Arlotta et al., 2008),
and mouse thymocytes (Leid M. et al., unpublished data).
CTIP2 is expressed early during mouse development as
well as in the adult animal, and in both cases, expression is
most predominant in the central nervous system, thymus, and
skin and other tissues of ectodermal origin (Leid et al., 2004;
Golonzhka et al., 2007). Mice null for expression of CTIP2
exhibit perinatal lethality and severe phenotypes in tissues
that express the gene. In the central nervous system, CTIP2 is
required for proper axonal projection by corticospinal
neurons and normal development of striatal medium spiny
neurons (Arlotta et al., 2005, 2008). Germline disruption of
CTIP2 results in an arrest of T-cell development at an
immature, CD4CD8 stage(s), with the complete absence of
ab T cells (Wakabayashi et al., 2003).
Here we report a previously unknown function of CTIP2 in
skin development. We show that CTIP2 controls epidermal
proliferation/differentiation programs and EPB formation.
CTIP2/ mice exhibit a hypoplastic epidermis, defects in
EPB development, and increased transepidermal water loss
(TEWL). These defects likely arise from large-scale disruption
of gene expression in the mutant skin, including genes
encoding structural protein and lipid modifying enzymes, as
well as those involved in epidermal proliferation and
differentiation, and EPB establishment. In the context of EPB
development, CTIP2 was found to function cell autono-
mously. However, the actions of CTIP2 in epidermal
proliferation and early differentiation were found to be non-
cell autonomous, most likely arising from CTIP2-dependent
regulation of paracrine growth factor(s) expression in the
dermis, including keratinocyte growth factor (KGF) and/or
GM-CSF (Szabowski et al., 2000; Werner and Smola, 2001).
RESULTS
Generation of total (CTIP2/) and epidermis-specific
(CTIP2ep/) CTIP2 knockout mice
CTIP2/mice were generated by floxing exon 4 of the CTIP2
locus, which encodes B75% of the CTIP2 open reading
frame and six zinc finger motifs (Figure 1a). The targeting
vector used to modify the CTIP2 locus by homologous
recombination (HR) is schematically depicted in Figure 1b
and c, and HR was confirmed by 50 and 30 Southern analyses
(Figure 1d and e). Heterozygous mice harboring one wild-
type (þ ) and one mutant CTIP2 allele (), did not show an
overt phenotype, and were viable and fertile. CTIP2þ / mice
were bred to generate the CTIP2/ mouse, and the lack of
CTIP2 protein in these mice was confirmed by immuno-
blotting in skin (Figure 1f). CTIP2/ mice were born at the
expected Mendelian ratio and without obvious skin abnorm-
alities, with the exception of an open eye phenotype (Figure
2a, arrow; compare; Figure S1a and b), as previously
described by Kominami and co-workers (Wakabayashi
et al., 2003). However, CTIP2/ mice did not feed and
died within 6–8 hours after birth. These phenotypic char-
acteristics, together with severe thymic hypocellularity and
complete loss of ab-T lymphocytes (data not shown),
recapitulated previously reported observations of CTIP2-null
mice (Wakabayashi et al., 2003).
CTIP2 floxed mice (CTIP2L2/L2; see Figure 1) were crossed
with a K14-Cre transgenic mouse (Indra et al., 2000) to obtain
a mouse line in which CTIP2 was specifically ablated in
keratinocytes (epidermis-specific knockout; CTIP2ep/). To
confirm excision of the floxed CTIP2 allele in CTIP2ep/
mice, we separated epidermis and dermis and genotyped
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Figure 1. Floxing the CTIP2 locus. (a) Schematic representation of the mouse
CTIP2 locus with exons 1–4 and corresponding amino acids (top). The vertical
black bars represent C2HC (exon 2) or C2H2 (exon 4) zinc finger motifs. (b)
Magnification of exon 4 and flanking sequences with selected restriction sites
and location of Southern probes. (c) Schematic representation of the CTIP2-
targeting vector indicating the direction of upstream and downstream LoxP
sites and PGK-neo. PGK-neo was flanked by Frt sites for excision by Flp
recombinase. Restriction sites were introduced into both the upstream and
downstream LoxP sites to facilitate analyses of HR at the CTIP2 locus. (d, e)
Southern analyses of HR at the CTIP2 locus using 50 (Probe A in panel b)
and 30 (Probe B in panel b) probes, respectively. The L3 genotype refers to
presence of the entire targeting vector, including the PGK-neo, in the CTIP2
locus by HR. Probe A hybridizes to 7.3 and 4.5 kb KpnI fragments, and Probe
B hybridizes to 5.1 and 3.1 kb PstI fragments from wt and L3 alleles,
respectively. (f) Immunoblot of whole cell extracts prepared from E18.5 skin
from CTIP2þ /þ and CTIP2/ mice using an anti-CTIP2 monoclonal
antibody. (g) Immunoblot of the protein extracts from epidermis of E18.5
CTIP2L2/L2 and CTIP2ep/ mice using an anti-CTIP2 monoclonal antibody.
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both tissues for excised () and floxed (L2) alleles. The
excised, but not L2, allele was detected in the epidermis of
E17.5 CTIP2ep/ fetuses, whereas only the L2 allele was
present in the dermis of these mice (Figure S1c), thus
demonstrating that CTIP2 was efficiently and selectively
ablated in the keratinocytes of the developing epidermis. In
agreement with this result CTIP2 protein was not detected in
epidermal extracts from CTIP2ep/ fetuses by immuno-
blotting, thus validating the CTIP2ep/ mouse model (Figure
1g). CTIP2ep/ mice were born without any apparent
abnormalities, fed normally, survived into adulthood, and
were fertile.
Loss of CTIP2 results in a compromised barrier function
CTIP2 is highly expressed in the mouse ectoderm during
development, beginning around embryonic day E10.5
(Golonzhka et al., 2007). To determine if the perinatal
lethality of CTIP2/ mice was due to defects in the EPB, we
investigated barrier function in these mice by performing
X-gal permeability assays at E17.5 and E18.5. Control
embryos showed very little X-gal staining at either E17.5
or E18.5 (Figure 2a, first and second panel). In contrast,
CTIP2/ fetuses stained strongly with X-gal at E17.5,
particularly on the ventral surface and head (Figure 2a). The
dorsal surface of CTIP2/ mice did not take up appreciable
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Figure 2. CTIP2 mutant mice exhibit permeability barrier defects and epidermal hypoplasia. (a) X-gal diffusion assay performed on CTIP2þ /þ , CTIP2/,
CTIP2L2/L2, and CTIP2ep/ fetuses at E17.5 and E18.5 as indicated. (b) Transepidermal water loss measurements from dorsal and ventral skin of CTIP2þ /þ ,
CTIP2/, CTIP2L2/L2, and CTIP2ep/ mice at E17.5 and E18.5. (Plotted are mean measurements of three independent mice per genotype±SEM). *Po0.05,
#not statistically significant. (c) Histology of toluidine blue stained dorsal skin biopsies (4-mm thick section) of CTIP2þ /þ and CTIP2/ mice at E18.5. Marked
epidermal hypoplasia was observed in CTIP2/mice. D, dermis; B, basal layer; S, spinous layer; G, granular layer; C, cornified layer. Scale bar: 50mm. (d) H&E
staining of dorsal skin biopsies (10-mm thick section) of CTIP2L2/L2 and CTIP2ep/ mice at E18.5. Abbreviations are as in (c). Scale bar: 50 mm. (e) Quantitative
histomorphometry of CTIP2/ and CTIP2ep/ phenotypes. Epidermal (Te) and dermal (Td) thicknesses were measured on eight independent wt (CTIP2þ /þ )
and null (CTIP2/) mice, and on six floxed (CTIP2L2/L2) and conditionally null (CTIP2ep/) mice. The ratio of Te to Td for the four genotypes is plotted on the
ordinate (left side). Bars on the right represent the number of proliferating Ki67þ cells (as a ratio of DAPIþ cells and expressed as percentage of each,
corresponding control). The asterisks and hash denotations are as described in (b), and refer to the comparison of CTIP2þ /þ and CTIP2/, and CTIP2L2/L2 and
CTIP2ep/ mice, respectively. The results depicted in this (a) to (d) are representative of 6–12 additional studies that have been conducted over the course of 2
years using numerous litters of mice of identical genotypes.
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amounts of X-gal, signifying that dorsal to ventral barrier
establishment had commenced in the mutants, but perhaps in
a delayed fashion. Similar studies conducted at E18.5
revealed that EPB function in CTIP2/ and wild-type (wt)
mice was indistinguishable, with the exception of blue
staining around the eyelids of the CTIP2/ mice (Figure
2a, arrow in second panel).
To determine if CTIP2 regulates EPB establishment in a
cell autonomous manner, we performed X-gal permeability
assays on CTIP2L2/L2 (as a control) and CTIP2ep/ mice at
E17.5 and E18.5 (Figure 2a, third and fourth panels). Similar
to CTIP2/ mice, CTIP2ep/ mice exhibited a delay in
barrier establishment. CTIP2ep/ mice showed extensive
blue staining on the ventral aspect of the body, limbs and
head at E17.5, and residual X-gal staining at E18.5, whereas
control embryos showed very little coloration at either E17.5
or E18.5 (Figure 2a). These results demonstrate that CTIP2, in
a cell autonomous manner, regulates EPB formation during
fetal development.
We also performed TEWL studies in CTIP2/ mice to
assess the rate of water evaporation from the skin at E17.5
and E18.5. At E17.5, TEWL from CTIP2/ dorsal skin
averaged B12 gm2 h1, which was about six-fold
higher than that of wt controls (Figure 2b, first panel).
The rate of water loss on the ventral surface of E17.5
CTIP2/ mice was approximately two-fold greater than
that of wt mice (Figure 2b). Although there was no difference
in dorsal water loss between wt and CTIP2/ mice at
E18.5, the ventral surface of the mutants continued to lose
water at a greater rate than wt controls (Figure 2d, second
panel).
The rate of water loss from the dorsal skin of E17.5
CTIP2ep/ mice was about three-fold higher than that of the
control mice (Figure 2b, third panel) but at E18.5 the water
loss on the dorsal surface of CTIP2ep/ mice was not
significantly different from controls (Figure 2b, fourth
panel). However, TEWL from the ventral side of CTIP2ep/
mice slightly exceeded that of the control mice at E17.5 and
was 2- to 3-fold higher than that of the control mice at E18.5.
These findings further demonstrate that CTIP2ep/ mice
exhibit considerably delayed formation of the EPB, recapitu-
lating the cell autonomous barrier phenotype of CTIP2/
mice. Together, these results indicate that skin barrier
establishment is disrupted in the absence of CTIP2, and
suggest a previously unreported role of CTIP2 in skin barrier
formation.
CTIP2-null mice exhibit altered expression of markers of
epidermal proliferation and early differentiation
Histological analyses of dorsal skin at E17.5 and E18.5
revealed that CTIP2/ epidermis was extremely hypoplastic
with decreased numbers of differentiating and cornified
cell layers, and profound loss of the normal, cornified layer
with the typical ‘‘basket weave’’ appearance (Figure 2c;
Figure S1d). The number of proliferating, Ki67þ cells in the
epidermis was modestly, but significantly reduced CTIP2/
mice (B13% reduction relative to wt controls; right panels
of Figure 2e), and the thickness of the CTIP2/ epidermis
was approximately 50% that of wt mice, as determined
by quantitative histomorphometry (left panels of Figure 2e).
All of the epidermal layers were present in the CTIP2ep/
mice, and both the number of proliferating cells and
the epidermal thickness of these conditionally null mice
were indistinguishable from that of the corresponding
control mice (CTIP2L2/L2; Figure 2e). However, we observed
a modest reduction in the number of cornified cell layers
in CTIP2ep/ mice at E17.5 and E18.5 (see Figure 2d;
Figure S1e).
Reduced epidermal thickness of the CTIP2/ mutants
could be due to alterations in epidermal proliferation and/or
differentiation. To test this, we performed immunohistochem-
ical analyses to assess the expression of: (1) a proliferation
marker (Ki67; Schluter et al., 1993), (2) a marker of
keratinocyte basal cells (keratin 14, K14; Byrne et al.,
1994), and (3) an early keratinocyte differentiation marker
(keratin 10, K10; Fuchs and Green, 1980; Roop et al., 1983).
Reduced numbers of Ki67þ cells (compare Figure 3a and d)
and reduced K14 staining (Figure 3b and e) were both
observed in the skin of CTIP2/ mice. Similarly, the
expression of the differentiation marker K10 was strongly
reduced in CTIP2/ mice (Figure 3c and f). Immunoblot
analyses of skin protein extracts further confirmed the
decrease in the expression of K10 and K14, in the mutant
fetuses (Figure 3w). These results suggest that reduced
epidermal thickness of the CTIP2/ fetuses may be due to
reduced proliferation and/or altered differentiation in the skin
of the mutant mice.
CTIP2 mutant mice exhibit altered epidermal terminal
differentiation
We performed immunohistochemical analyses of the late
epidermal differentiation markers loricrin, involucrin, and
filaggrin. The expression levels of involucrin and filaggrin,
Figure 3. Decreased expression of epidermal markers and genes involved in epidermal barrier establishment in CTIP2 mutant mice. (a–f)
Immunohistochemistry of dorsal skin of CTIP2þ /þ and CTIP2/ mice at E18.5. Genotypes and antibodies (red staining) used are indicated, and all sections
were counterstained with DAPI (blue). (g–l) Immunohistochemistry of dorsal skin with late differentiation markers loricrin, involucrin, and filaggrin (all in red) in
CTIP2þ /þ and CTIP2/ mice at E18.5. All sections were counterstained with DAPI (blue). White arrows in g and h indicate expression of filaggrin (g) and
involucrin (h) in the cornified cell layers. White asterisks in j and k indicate the reduction in filaggrin (j) and involucrin (k) expression. (m–v)
Immunohistochemistry of dorsal skin of CTIP2L2/L2 and CTIP2ep/ mice at E18.5. Genotypes and antibodies (red staining) used are indicated, and all sections
were counterstained with DAPI (blue). Scale bar in l: 100 mm for a–l; scale bar in v: 100mm for m–v. (w) Immunoblot of dorsal skin extracts from CTIP2þ /þ and
CTIP2/ mice at E18.5 using indicated antibodies. (x) RT-qPCR analysis of dorsal skin from CTIP2þ /þ and CTIP2/ mice at E18.5. Relative expression levels
for all genes are shown on y axis to the left, except for c-Fos and c-Jun, which are plotted on the right y axis. Statistical significance denotations: *Po0.05;
**Po 0.01; ***Po0.001; #no statistically significant difference between wt and mutant mice. The results depicted in this figure are representative of at least
eight additional studies that have been conducted over the course of two years using numerous litters of mice of identical genotypes.
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but not that of loricrin, were reduced in the E18.5 CTIP2/
skin (compare Figure 3g and j, h and k, i and l, respectively),
and this was further confirmed by immunoblotting
(Figure 3w).
Immunohistochemical analyses of the CTIP2ep/ skin
revealed no changes in K14 expression (compare Figure 3m
and r) and a slight reduction in the expression of K10 relative to
control skin (compare Figure 3n and s). Involucrin and filaggrin
expression levels were slightly reduced in the upper, terminally
differentiating cell layers in the mutants (white arrows in Figure
3o and t and p and u). However, loricrin levels were
comparable in wt and mutant skin (Figure 3q and v).
Our data indicates that CTIP2/ mice exhibit defects in
keratinocytic proliferation, early differentiation, terminal
differentiation, and EPB formation. CTIP2ep/ mutants on
the other hand did not demonstrate severe epidermal
proliferation or early differentiation defects. However,
CTIP2ep/ mice did exhibit impaired terminal differentiation
and EPB establishment, as was observed in the CTIP2/
mice. This suggests a cell autonomous function of CTIP2 in
controlling the terminal differentiation events, and non-cell
autonomous influence of CTIP2 on proliferation and early
differentiation of keratinocytes.
CTIP2-null mice exhibit altered expression of a subset of genes
involved in the epidermal terminal differentiation and barrier
formation
We performed RT-qPCR analyses to assess expression levels
of several genes implicated in the control of early- and late-
differentiation events in the epidermis, as well as genes
involved in barrier establishment. Interestingly, although
expression of Id2 and p57 was upregulated (or derepressed)
in the mutant skin, consistent with the previously demon-
strated repressor activity of CTIP2 (Senawong et al., 2003;
Topark-Ngarm et al., 2006) expressions of both c-Myc and
p63 were downregulated in the mutants at E18.5 (Figure 3x),
suggesting that CTIP2 may directly or indirectly activate
expression of the latter two genes. RT-qPCR analyses for
genes encoding structural proteins and transcription factors
involved in late terminal differentiation and barrier formation,
such as transglutaminase-1 (Tgase1), GATA3, Klf4, and
caspase-14 revealed that all were downregulated at both
E17.5 and E18.5 in the mutants (Figure 3x and data not
shown). We also observed a significant downregulation of
c-Fos, but not c-Jun, suggesting that altered gene expression
in CTIP2 mutant skin may be mediated, at least in part, by
specific members of AP-1 family of transcription factors
(Shaulian and Karin, 2002; Zenz and Wagner, 2006).
Altogether, our data suggest that CTIP2 regulates expression
of a subset of the keratinocytic genes encoding transcription
factors and other proteins implicated in the epidermal
homeostasis and EPB formation.
CTIP2 mutant mice exhibit defects in surface lipid distribution
and decreased expression of lipid-metabolizing enzymes
To determine if the observed barrier defect in the CTIP2/
mutants was due to the altered distribution of polar and
neutral lipids, we analyzed the surface lipid distribution of
mutant and wt epidermis by Nile Red staining. These studies
revealed that neutral lipids formed a yellow-colored and
dense, continuous ribbon along the top of the cornified layer
in control fetuses but these lipids were unevenly distributed
along the cornified layer of the CTIP2-null epidermis
(compare Figure 4a and b). Nile Red staining performed on
E17.5 CTIP2ep/ skin confirmed that the surface distribution
of neutral lipids was impaired (compare Figure S1f and g).
These results suggest a possible alteration in the composition
of the neutral lipids of the skin in the absence of CTIP2, and
this effect seems to be due to a cell autonomous effect of
CTIP2 in keratinocytes.
Ultrastructural analysis of the epidermis from E17.5
fetuses did not reveal differences in basal or spinous cell
populations between control and CTIP2 mutants (data not
shown). Likewise, similar numbers of desmosomes (D),
keratohyaline granules (KG), keratin filaments (KF), and
lamellar granules (LG; also called keratinosomes) were
present in the granular cells of both control and CTIP2/
mice (Figure 4c and d; and data not shown). Lipid discs that
were extruded from the LGs were uniformly aligned and
formed lipid lamellar membranes at the interface of granular
and cornified cells in control fetuses (Figure 4e). In contrast,
lipid discs were replaced by large vesicles (marked by arrows
in Figure 4f), and the intercellular (lipid) lamellar membranes
(LL) in cornified layers were disorganized and highly variable
in thickness in the mutant epidermis (compare Figure 4g–h,
and i–j). Similar numbers of corneodesmosomes (CD) were
present between the cornified cells in both control and
mutant skin, however, the mutant CDs were smaller in size
than the controls, and the mutant corneocytes were loosely
packed (Figure 4h and j). These results suggest that the
impaired barrier formation in the CTIP2 mutant fetuses could
be, at least in part, due to altered lipid metabolism in the
developing skin.
The results of Nile Red staining and transmission electron
microscopy studies prompted us to perform RT-qPCR
analyses for genes encoding proteins that are implicated in
lipid homeostasis in the developing skin (Figure 4k).
RT-qPCR revealed dysregulated expression of Smpd3
(Mao-Qiang et al., 1996; Gurrieri et al., 2003), Dgat2 (Stone
et al., 2004), Elovl4 (Cameron et al., 2007; Li et al., 2007;
Vasireddy et al., 2007), eLox3 (Furstenberger et al., 2007),
and Alox12b (Moran et al., 2007), but not of Gba2 (Holleran
et al., 1994) or Pla2gV in the skin of CTIP2-null mice
compared to wt controls (Figure 4k). These results suggest
that CTIP2 might regulate the expression of genes implicated
in lipid metabolism and in the formation of extracellular lipid
matrix.
To gain insights into the molecular mechanisms of
permeability barrier defects in the conditional CTIP2ep/
mice, we performed expression profiling of dorsal skin RNA
from E17.5 CTIP2ep/ and CTIP2L2/L2 mice. We found that
out of the total 45,000 probe sets, only 1,688 probe sets,
corresponding to 750 unique genes were significantly altered
in the conditional mutants (up- or downregulated; Table S1),
indicating that epidermal-specific deletion of CTIP2 leads to a
highly selective (o1%) alteration in gene expression.
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The transcriptome analyses also revealed that a subset of
genes implicated in lipid homeostasis was downregulated in
CTIP2ep/ epidermis (Table S1). RT-qPCR analyses of several
of the differentially expressed genes confirmed the down-
regulation of genes involved in the lipid metabolism (Dgat2,
Elovl4, eLox3, Alox12b) as well as Tgase1, which is
implicated in the terminal differentiation of skin (Figure 4l).
Approximately half of the genes within the epidermal
differentiation complex, which is located in two adjacent
bands on chromosome 3 (3qF1 and 3qF2.1; see Figure S2)
and encodes structural proteins of the CE, were found to be
dysregulated in CTIP2ep/ mice, and the majority of those
were downregulated in mutant skin (Figure S2). Altogether,
these findings suggest that CTIP2, in a cell-autonomous
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mice of each genotype.
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manner, regulates expression of a subset of genes implicated
in the lipid metabolism and skin barrier formation.
CTIP2 is involved in controlling the mesenchymal–epithelial
cross-talk through regulation of secretion of paracrine factors in
the dermis
Our data suggest that CTIP2, in a cell autonomous manner,
plays a contributory role in the late keratinocyte differentia-
tion events and EPB formation. However, the epidermal
proliferation defect seen in CTIP2/ mice was not recapi-
tulated in CTIP2ep/ conditional mutants, suggesting that the
effect of CTIP2 on keratinocyte proliferation may be the result
of non-cell autonomous action(s) of CTIP2. To test this
hypothesis we analyzed the expression levels of several
diffusible factors known to be involved in the control of
keratinocyte proliferation, including KGF, GM-CSF, and
heparin-binding EGF-like growth factor (HBEGF), in the skin
of wt, CTIP2/, and CTIP2ep/ fetuses. Notably, the
expression of KGF was found to be downregulated by almost
60% in the CTIP2/ mice; however, the expression levels of
KGF in wt and CTIP2ep/ skin were indistinguishable
(Figure 5). Reduced expression of KGF in the dermis of the
total knockout mice could be partially responsible for the
observed hypoplasticity of the CTIP2/ epidermis (Figure
2c). CTIP2 expression is preserved in the dermis of CTIP2ep/
mice, and the levels of KGF are normal in these mice, which
could explain development of a morphologically normal
epidermis (Figure 2d), and underlie the non-cell autonomous
action of CTIP2 in epidermal development. We also observed
a slight downregulation of GM-CSF and HBEGF in the skin of
CTIP2/ mice, although the levels of these transcripts were
similarly downregulated in CTIP2ep/ mice (Figure 5). Thus,
it seems unlikely that GM-CSF and HBEGF contribute to the
non-cell autonomous actions of CTIP2 in the epidermis.
DISCUSSION
We identify herein a key regulator of gene expression and the
developmental program responsible for establishment of the
EPB during skin organogenesis. In the absence of CTIP2, the
epidermal developmental program was perturbed leading to
the thinning of the epidermis with a corresponding reduction
in a number of differentiated cell layers. Terminal keratino-
cyte differentiation was also impaired, most likely owing to
disrupted gene expression in CTIP2 mutant mice (both null
and conditional), contributing to a delay in EPB establishment
and increased TEWL. Thus, CTIP2 appears to be a critical
regulator of skin developmental processes, in which it
functions in both cell and non-cell autonomous contexts.
CTIP2 is required for epidermal barrier establishment
The results of X-gal diffusion assays indicated that barrier
formation was severely disrupted in CTIP2/ mice at E17.5
but this defect was largely overcome by E18.5, suggesting
that barrier formation was most likely delayed in CTIP2/
mice. However, a substantial degree of epidermal hypocel-
lularity was observed in CTIP2/ mice at E18.5, which led
us to conclude that EPB formation and/or function remained
disrupted in CTIP2/ mice at this developmental stage.
Indeed, TEWL measurements taken at E18.5 demonstrated an
increased rate of water loss in CTIP2/ mice as compared to
wt controls, demonstrating that barrier defects persisted at
E18.5 in the mutants. The apparent disparity between results
of X-gal and TEWL assays in the mutant mice at E18.5 may be
due to the insensitivity of the former assay. Nonetheless, it is
unquestionably true that the barrier defect is less severe at
E18.5 than at E17.5 in CTIP2/ mice, and this may be
explained by compensatory mechanisms. The highly related
CTIP1 is expressed in skin (Figure S1) and shares many
functional properties with CTIP2. For example, both CTIP1
and CTIP2 interact with COUP-TF family members (Avram
et al., 2000), exhibit identical sequence-specific DNA-
binding activity (Avram et al., 2002), and repress transcrip-
tion via similar mechanisms (Senawong et al., 2003, 2005;
Cismasiu et al., 2005; Topark-Ngarm et al., 2006). Although
the distribution and function of CTIP1 in skin are unknown,
CTIP1 could, in principle, compensate for the lack of CTIP2,
which may explain the ‘‘recovery’’ of the barrier defect that
we observe at E18.5 in CTIP2/ and CTIP2ep/ mice.
Consistent with this hypothesis we detected a modest
upregulation of CTIP1 expression in the epidermal extracts
of CTIP2ep/ mice as compared to those prepared from wt
animals (Figure S1).
Barrier defects can be caused by inappropriate expression
of proteins involved in the assembly and cross-linking of the
CE, and/or inadequate lipid processing in the granular
and cornified layers, which can result in defective lipid
lamellae formation. Gene expression profiling performed on
CTIP2ep/ mice revealed that CTIP2, directly or indirectly,
regulated the expression of a subset of genes of the epidermal
differentiation complex, as well as a number of lipid
metabolizing enzymes in skin. Thus, it seems likely that
dysregulation expression of these putative CTIP2 target genes
contributed to the delay in EPB formation in both CTIP2/
and CTIP2ep/ mice.
The irregular distribution of neutral surface lipids (and
increased water loss through the breached areas), and
abnormal lipid discs and lipid lamellar structures in the
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mesenchymal–epithelial cross-talk. RT-qPCR analysis of genes encoding
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using at least three independent mice of each genotype.
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mutant mice may be a consequence of the relative deficiency
of lipid-metabolizing enzymes in CTIP2 mutant mice.
Mutations in and/or inhibition of lipid-metabolizing enzymes,
such as Elovl4, Dgat2, Gba2, Smpd3, Alox12b, eLox3,
Pla2gV, and Pla2gVI have been linked to alteration in barrier
integrity (Mao-Qiang et al., 1996; Gurrieri et al., 2003; Stone
et al., 2004; Cameron et al., 2007; Epp et al., 2007;
Furstenberger et al., 2007; Vasireddy et al., 2007). Terminal
differentiation of keratinocytes and EPB formation were
similarly affected in skin of CTIP2/ and CTIP2ep/ mice,
strongly suggesting a cell-autonomous effect of CTIP2 in the
keratinocyte lineage.
CTIP2 is involved in epidermal homeostasis and control of
keratinocyte proliferation and differentiation
The hypoplasticity of CTIP2/ epidermis is most likely
the result of insufficient proliferation and/or altered differ-
entiation. CTIP2 is expressed in all basal cells, some
suprabasal cells, and a K15þCD34 population of stem cells
(Golonzhka et al., 2007). We observed a reduction in
epidermal proliferation and early differentiation in the skin
of CTIP2/ mice compared to control mice, which was
accompanied by a concomitant downregulation of the
expression of several factors that are implicated in the control
of epidermal proliferation and differentiation, including p63,
c-Myc, GATA3, c-fos, Klf4, and KGF (Byrne et al., 1994; Mills
et al., 1999; Pelengaris et al., 1999; Waikel et al., 1999; Yang
et al., 1999; Yokota et al., 1999; Grachtchouk et al., 2000;
Langlands et al., 2000; Arnold and Watt, 2001; Mill et al.,
2003; Koster et al., 2004, 2007; Simbulan-Rosenthal et al.,
2005; Yu et al., 2006; de Guzman Strong et al., 2006). These
results strongly suggest that CTIP2 directly or indirectly
regulates the promoters of all of these genes. Interestingly,
expression of Id2 and p57 was upregulated in CTIP2/
epidermis. p57 (Topark-Ngarm et al., 2006) and Id2 (Leid M.
et al., manuscript in preparation) are known, direct targets of
CTIP2 in neuroblastoma cells and thymocytes, respectively,
and it is very likely that CTIP2 directly regulates expression of
both genes in keratinocytes as well.
As was observed in CTIP2/mice, conditional ablation of
CTIP2 in keratinocytes resulted in delayed EPB formation in
the CTIP2ep/mice. However, conditional ablation of CTIP2
in keratinocytes did not significantly alter the proliferation or
early differentiation programs of these cells, and the
epidermis of CTIP2ep/ mice was similar to that of wt mice.
This demonstrates that CTIP2 is dispensable for keratinocyte
proliferation and early differentiation events. In that case it
would appear that CTIP2 is acting non-cell autonomously,
possibly by controlling the expression of secreted dermal
factors that regulate epidermal morphogenic events in a
paracrine fashion. Indeed, we observed downregulation of
KGF, a dermal fibroblast-derived growth factor, in CTIP2/,
but not in CTIP2ep/ mice, suggesting that KGF may play a
role in the non-cell autonomous actions of CTIP2 in
keratinocytes. Interactions between mesenchymal and
epithelial cells play an important role in regulating tissue
development and homeostasis (Ronnov-Jessen et al., 1996;
Angel et al., 2001; Angel and Szabowski, 2002). Similarly,
non-cell autonomous effects in skin have been reported for
c-Jun and IKK1 (Szabowski et al., 2000; Gareus et al., 2007).
KGF and GM-CSF, which are both downstream of c-Jun, were
identified as key regulators of a paracrine loop responsible for
the finely tuned balance of keratinocyte proliferation and
differentiation (Szabowski et al., 2000). c-Jun also regulates
expression of HBEGF and EGFR in keratinocytes in a cell
autonomous manner, and mice lacking c-Jun specifically in
epidermis do not display an obvious skin phenotype (Li et al.,
2003; Gareus et al., 2007). Interestingly, we did not observe a
significant alteration of c-Jun expression in skin of CTIP2/
or CTIP2ep/ mice, suggesting that CTIP2 is either down-
stream of c-Jun or represents a parallel pathway by which
expression of KGF, GM-CSF, and HBEGF is regulated in the
skin. Mice harboring a germline deletion of IKK1 exhibit
severe defects in epidermal differentiation, defective EPB
function, and increased TEWL, much like CTIP2/ mice (Li
et al., 1999). The epidermis of keratinocyte-specific IKK1
knockout mice develops normally in a histological/morpho-
logical sense, but this mouse still displays an impaired barrier
and increased TEWL (Gareus et al., 2007). Further analysis of
IKK1 total knockouts revealed that IKK1 may influence
epidermal development in a non-cell autonomous fashion
thorough the regulation of expression/release of yet unidenti-
fied diffusible factor(s) from the dermis (Gareus et al., 2007).
Nonetheless, the parallels between the cell and non-cell
autonomous actions of CTIP2 and IKK1 in the epidermis are
striking, and suggest a possible convergence in the two
pathways within dermal fibroblasts.
In this study, epidermal keratinocyte-specific ablation of
CTIP2 gene revealed that CTIP2 cell autonomously controls
barrier establishment in a multifaceted fashion, affecting all
stages of this process. Every cell derived from basal
keratinocytes in the CTIP2ep/ mice is presumably null for
CTIP2 expression, and this was confirmed by immunoblot
analysis. However, it is possible that CTIP2 plays a specific
role(s) in suprabasal cell population(s) of the epidermis and
this can be further addressed by specifically deleting CTIP2
locus in suprabasal cells, as previously described (Calleja
et al., 2006).
Finally, expression-profiling studies reported herein iden-
tified genes that were both upregulated and downregulated in
the absence of CTIP2 in the epidermis. The mechanistic basis
of CTIP2-mediated transcriptional repression has been
described (Senawong et al., 2003; Cismasiu et al., 2005;
Topark-Ngarm et al., 2006), and presumably the upregulated
genes were simply derepressed in the absence of CTIP2.
However, the majority of the genes identified herein by
expression profiling analyses of CTIP2ep/ mice were found
to be downregulated in absence of CTIP2. This could either
represent an indirect effect of CTIP2 ablation or a direct effect
of the absence of CTIP2 on the promoters of the correspond-
ing genes, the latter of which may involve recruitment of the
coactivators p300 and/or CBP to the target promoter
templates (Cismasiu et al., 2006). Further analyses will be
required to unravel the mechanism(s) of bidirectional
transcriptional regulation mediated by CTIP2 in skin in both
health and disease.
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MATERIALS AND METHODS
Generation of CTIP2/ mice
A 14 kb fragment of the mouse CTIP2 genomic locus (129SvPAS
strain) was used to construct a CTIP2-targeting vector (Figure 1b and
c). After electroporation, five ES cell lines (out of 568) were verified
to have undergone HR as judged by Southern analysis using 50 and 30
probes outside the targeting vector. Two of these clones were
injected into blastocysts, and both gave rise to chimeric animals that
were bred with C57BL/6 mice to establish germ line transmission of
the targeted L3 allele. These mice were bred with transgenic mice
expressing the Flp recombinase under the control of the cytomega-
lovirus promoter (Rodriguez et al., 2000) to excise the neo marker
and generate the L2 (floxed) CTIP2 allele. Alternatively, mice
harboring the L3 allele (LoxP–Exon 4–Frt-PGKneo–Frt–LoxP) were
crossed with transgenic mice expressing Cre recombinase under the
control of the cytomegalovirus promoter (Dupe et al., 1997), to
excise both the floxed CTIP2 exon 4 (and generate L-allele) as well as
the neo marker. These mice were bred to homozygosity (CTIP2L/L,
referred to as CTIP2/ hereafter). Approval for the animal
experiments was obtained from the OSU Institutional Animal Care
and Use Committee.
X-Gal permeability assay and transepidermal water loss
X-Gal diffusion assays were performed as described previously
(Hardman et al., 1998) with minor modifications. TEWL was
assessed using a vapometer (SWL4142; Delfin Technologies). Data
was expressed in gm2 h1, and represents the mean±SEM from
three independent animals (three independent measurements per
animal) of each genotype. Data were compared using an unpaired
Student’s t-test, with corrections for unequal variance.
Antibodies
The following antibodies and their dilutions were used for
immunohistochemistry: anti-CTIP2 (Abcam, Cambridge, UK
1:300), anti-K1 (Covance, Denver, PA, 1:1,000), anti-K14 (Covance,
1:1,000), anti-K10 (Covance, 1:1,000), anti-Ki67 (Abcam, 1:500),
anti-Involucrin (Covance, 1:1,000), anti-Loricrin (Covance, 1:1,000),
Filaggrin (Covance, 1;1,000). For Immunoblotting we used the
dilutions mentioned above, except for anti-CTIP2 (1:1,000 dilution),
anti-CTIP1 (Abcam) (1:500) and anti-b-Actin (1:4,000).
Immunohistochemistry
Fetuses at E17.5 and E17.5 were collected, fixed with 4%
paraformaldehyde, cryopreseved in 30% sucrose and frozen
down in optical coherence tomography. Cross-sections (10mm) were
rinsed with phosphate-buffered saline (PBS) three times, permeabi-
lized with ice-cold methanol for 3minutes, and blocked with
blocking buffer (0.3% Boehringer Mannheim blocking reagent, 5%
horse serum, 5% fetal calf serum, and 0.1% triton X-100 in PBS).
Sections were then incubated with primary antibodies overnight,
followed by three washes with PBSþ 0.01% Tween and incubation
with fluorescently labeled secondary antibody (Cy2, 1:250 or Cy3,
1:500; Jackson ImmunoResearch, West Grove, PA) for 2 hours at
room temperature. Nuclei were visualized using DAPI. After final
washes with PBSþ 0.01% Tween, sections were dehydrated through
a series of ethanol washes, cleared in xylene, and mounted with DPX
mounting media. All images were captured at 40 magnification
using Leica DMRA fluorescent microscope and Hamamatsu C4742-
95 digital camera and processed using OpenLab software and Adobe
Photoshop 7.0.
Ki67þ cells were quantified and used as a measure of epidermal
proliferation. For this, the number of Ki67þ cells within a field of
fixed size was determined and expressed as a percentage of DAPIþ
cells (total cells) in that same field. The percentage value for wt or
L2/L2 controls (approximately 60% across several fields and multiple
mice) was then set to 100% for the purposes of comparing the
number of epidermal proliferating cells in / mice or the
conditional mutants.
Histological analysis
Toluidine blue and Hematoxylin and Eosin staining of 1.5 and
10 mm-thick skin sections, respectively, were performed as described
(Indra et al., 2005a, b). For transmission electron microscopy
analysis, 70 nm, ultra-thin sections were processed as described
(Indra et al., 2005b).
Nile Red staining
Frozen sections (10 mm) were stained with Nile Red and after
2minutes examined with a Leitz fluorescence microscope (excita-
tion 489 nm, emission 515 nm; Indra et al., 2005a, b).
RT-qPCR
RNA extraction and cDNA preparation were performed as described
(Indra et al., 2005b). Real-time PCR was performed on an ABI 7500
Real-Time PCR system using SYBR green methodology as described
(Indra et al., 2005a, b). RT-PCR conditions and primers sequences for
most of the genes have been previous described (Indra et al.,
2005a, b; Rodius et al., 2007). Other primer sequences are described
in the Supplementary Methods section. Statistical analyses for qPCR
experiments were conducted as described for TEWL measurements.
Microarray analysis
Total RNA was prepared from whole skin biopsies using Qiagen,
Valencia, PA, RNeasy Mini kit. Probe synthesis, hybridization and
scanning were conducted by the Center for Genome Research and
Biocomputing Core Laboratories at Oregon State University. The
integrity and concentration of RNA was assessed using Bioanalyzer
2100 (Agilent Technologies, Santa Clara, CA), and used to prepare the
cDNA templates from which the cRNA probes were synthesized.
Probes were hybridized to the Affymetrix Mouse Genome 430 2.0
arrays, and the results were analyzed using GeneSpring 7.2 (Agilent
Technologies, Santa Clara, CA) software. Genes that differed from the
control by at least 1.5-fold (Po0.05 as determined by one-way analysis
of variance) were further filtered by confidence level using Benjamini
and Hochberg False Discovery Rate (o20%).
Skin protein extraction
Whole skin biopsies were homogenized in RIPA buffer (50mM Tris,
pH 7.5, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 150mM
NaCl, 5mM EDTA, proteinase inhibitors) with a tissue homogenizer,
and cleared by centrifugation. Supernatants were collected and
equal amounts of protein were analyzed by immunoblotting with
indicated antibodies. Where indicated, epidermis was separated
from the underlying dermis by incubating the whole skin biopsies
with the dispase solution (4mgml1) for 4 hours at room tempera-
ture. Epidermal protein extracts were prepared as described above.
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